Oncology 3.0: Towards Personalized Cancer Treatment

Oncology 3.0: Towards Personalized Cancer Treatment
Course organized within the CTO program of the Utrecht Graduate School of Life Sciences
Location lectures: Stratenum 2.112
26-28 November 2014
November 26: Genomics/Genetics
09:30 The future of Medical Oncology: what do we need?
Prof. dr. Emile Voest, Medical Director of the Netherlands Cancer Institute
10:30 Coffee break
10:45 NGS technology: Platforms and assays to detect mutations, structural
variations and copy number variations
Marco Koudijs, PhD, Clinical laboratory geneticist i.t., UMC Utrecht
11:45 Whole genome sequencing in diagnostics
Jan Molenaar MD PhD, Postdoc Pediatric Oncology, AMC Amsterdam (onder voorbehoud)
12:45 Lunch break
13:30 Ethical issues: unexpected findings and informed consent
Annelien Bredenoord PhD, Julius Center Utrecht
14:30 Practial session (same cases as last year) :
Ies Nijman PhD Annelies Smouters?, UMC Utrecht
- Cases
- Databases
16:30 End
November 27: Proteomics and data-integration
09:00 Transcriptomics
Lodewyk Wessels, NKI Amsterdam
10:00 Proteomics 2
Connie Jimenez, VU MC Amsterdam
11:00 Coffe break
11:15 TRAIT
Gerrit Meijer, VU MC Amsterdam
12:15 Lunch break
13:15 Practical session: TransMart/TRAiT
Remond Fijneman VU MC Amsterdam
14:15 R2 workshop
Jan Koster, AMC
16:30 End
November 28: Drug screens
09:00 Crystallography and drug development
Michael Hadders, Postdoc Lens Group UMCU
10:00 Do’s and don’ts in Biotech development
Roel Raatgever, managing director UtrechtINC
11:00 Coffee break
11:15 Compound screening (Company)
Ruben Postel PhD, Senior Scientist at Somantix, Utrecht
12:15 Lunch Break
13:15 Discussion panel Pharma/Insurance company/Doctor/Researcher/Ethicist
Edwin Cuppen, Terry Vrijenhoed (mediator), ………
15:30 End of course